Literature DB >> 25819753

ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal.

Arash Nabbi1, Amal Almami1, Satbir Thakur1, Keiko Suzuki1, Donna Boland1, Tarek A Bismar2, Karl Riabowol3.   

Abstract

Members of the INhibitor of Growth (ING) family of proteins act as readers of the epigenetic code through specific recognition of the trimethylated form of lysine 4 of histone H3 (H3K4Me3) by their plant homeodomains. The founding member of the family, ING1, was initially identified as a tumor suppressor with altered regulation in a variety of cancer types. While alterations in ING1 and ING4 levels have been reported in a variety of cancer types, little is known regarding ING3 protein levels in normal or transformed cells due to a lack of reliable immunological tools. In this study we present the characterization of a new monoclonal antibody we have developed against ING3 that specifically recognizes human and mouse ING3. The antibody works in western blots, immunofluorescence, immunoprecipitation and immunohistochemistry. Using this antibody we show that ING3 is most highly expressed in small intestine, bone marrow and epidermis, tissues in which cells undergo rapid proliferation and renewal. Consistent with this observation, we show that ING3 is expressed at significantly higher levels in proliferating versus quiescent epithelial cells. These data suggest that ING3 levels may serve as a surrogate for growth rate, and suggest possible roles for ING3 in growth and self renewal and related diseases such as cancer.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Epigenetic regulator; Histone code; Monoclonal antibody; PHD protein; Tissue expression; Tumor suppressor

Mesh:

Substances:

Year:  2015        PMID: 25819753     DOI: 10.1016/j.ejcb.2015.03.002

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  11 in total

Review 1.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

Review 2.  ING Proteins: Tumour Suppressors or Oncoproteins.

Authors:  Karine Jacquet; Olivier Binda
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

3.  Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer.

Authors:  Huimeng Li; Hengyu Zhang; Xin Tan; Dequan Liu; Rong Guo; Maohua Wang; Yiyin Tang; Kai Zheng; Wenlin Chen; Hongwan Li; Mingjian Tan; Ke Wang; Rui Liu; Shicong Tang
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

4.  Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.

Authors:  Marjolaine Ngollo; Andre Lebert; Marine Daures; Gaelle Judes; Khaldoun Rifai; Lucas Dubois; Jean-Louis Kemeny; Frederique Penault-Llorca; Yves-Jean Bignon; Laurent Guy; Dominique Bernard-Gallon
Journal:  BMC Cancer       Date:  2017-04-12       Impact factor: 4.430

5.  Genome-scale Capture C promoter interactions implicate effector genes at GWAS loci for bone mineral density.

Authors:  Alessandra Chesi; Yadav Wagley; Matthew E Johnson; Elisabetta Manduchi; Chun Su; Sumei Lu; Michelle E Leonard; Kenyaita M Hodge; James A Pippin; Kurt D Hankenson; Andrew D Wells; Struan F A Grant
Journal:  Nat Commun       Date:  2019-03-19       Impact factor: 14.919

Review 6.  The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer.

Authors:  Elisabeth Smolle; Nicole Fink-Neuboeck; Joerg Lindenmann; Freyja Smolle-Juettner; Martin Pichler
Journal:  Cancers (Basel)       Date:  2019-08-06       Impact factor: 6.639

Review 7.  Focus-ING on DNA Integrity: Implication of ING Proteins in Cell Cycle Regulation and DNA Repair Modulation.

Authors:  Jérôme Archambeau; Alice Blondel; Rémy Pedeux
Journal:  Cancers (Basel)       Date:  2019-12-24       Impact factor: 6.639

8.  Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3.

Authors:  Sophia Kim; Senthil Natesan; Gabriel Cornilescu; Samuel Carlson; Marco Tonelli; Urszula L McClurg; Olivier Binda; Craig N Robson; John L Markley; Stefan Balaz; Karen C Glass
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

9.  ING3 promotes prostate cancer growth by activating the androgen receptor.

Authors:  Arash Nabbi; Urszula L McClurg; Subhash Thalappilly; Amal Almami; Mahsa Mobahat; Tarek A Bismar; Olivier Binda; Karl T Riabowol
Journal:  BMC Med       Date:  2017-05-16       Impact factor: 8.775

10.  Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein.

Authors:  Urszula L McClurg; Arash Nabbi; Charles Ricordel; Svitlana Korolchuk; Stuart McCracken; Rakesh Heer; Laura Wilson; Lisa M Butler; Bronwyn Kate Irving-Hooper; Rémy Pedeux; Craig N Robson; Karl T Riabowol; Olivier Binda
Journal:  Br J Cancer       Date:  2018-01-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.